TRV
42
-4
INTC
22
-6
XOM
44
5
CI
52
2
DOV
49
7
AEE
66
-5
HUM
36
-9
MU
64
-4
TSCO
56
-3
WFC
63
-3
TAP
31
-4
PCG
45
-3
CNX
52
3
PYPL
58
-16
PX
43
-6
EFX
58
-8
TGNA
35
-5
MTCH
40
-4
FRT
41
-5
TEL
54
-7
TRV
42
-4
INTC
22
-6
XOM
44
5
CI
52
2
DOV
49
7
AEE
66
-5
HUM
36
-9
MU
64
-4
TSCO
56
-3
WFC
63
-3
TAP
31
-4
PCG
45
-3
CNX
52
3
PYPL
58
-16
PX
43
-6
EFX
58
-8
TGNA
35
-5
MTCH
40
-4
FRT
41
-5
TEL
54
-7
Financhill
Back

Rocket Pharmaceuticals Vs. Lixte Biotechnology Holdings Industry Stock Comparison

Sell
14

RCKT
Rocket Pharmaceuticals

Last Price:
$2.94
Seasonality Move:
5.53%
Sell
14

LIXT
Lixte Biotechnology Holdings

Last Price:
$1.12
Seasonality Move:
15.27%
Sell
14
Rocket Pharmaceuticals (RCKT) is a Sell

Is Rocket Pharmaceuticals a Buy, Sell or Hold?

  • The current Rocket Pharmaceuticals [RCKT] share price is $2.93. The Score for RCKT is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
  • RCKT is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
14
Lixte Biotechnology Holdings (LIXT) is a Sell

Is Lixte Biotechnology Holdings a Buy, Sell or Hold?

  • The current Lixte Biotechnology Holdings [LIXT] share price is $1.14. The Score for LIXT is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
  • LIXT is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

RCKT Stock Price Chart

What is Rocket Pharmaceuticals's stock price today?

  • The Rocket Pharmaceuticals share price today is $2.93
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RCKT is experiencing selling pressure, which indicates risk of future bearish movement.

LIXT Stock Price Chart

What is Lixte Biotechnology Holdings's stock price today?

  • The Lixte Biotechnology Holdings share price today is $1.14
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LIXT is experiencing slight buying pressure.

RCKT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.92 Sell
Relative Strength Index (14 RSI): 33.01 Sell
Chaikin Money Flow: -2719636 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.6 - 6.38) Sell
Bollinger Bands (100): (4.95 - 9.97) Sell

LIXT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.01 Sell
Relative Strength Index (14 RSI): 41.15 Sell
Chaikin Money Flow: 8333 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.24 - 1.4) Sell
Bollinger Bands (100): (1.01 - 1.91) Sell

RCKT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3 Sell
20-day SMA: 3.94 Sell
50-day SMA: 5.5 Sell
200-day SMA: 11.61 Sell
8-day EMA: 3.08 Sell
20-day EMA: 3.85 Sell
50-day EMA: 5.4 Sell
200-day EMA: 10.89 Sell

LIXT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.29 Sell
20-day SMA: 1.31 Sell
50-day SMA: 1.27 Sell
200-day SMA: 1.7 Sell
8-day EMA: 1.27 Sell
20-day EMA: 1.29 Sell
50-day EMA: 1.32 Sell
200-day EMA: 1.71 Sell

Rocket Pharmaceuticals Earnings Growth & RCKT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.22 per share, an increase next quarter of $0.17 per share, an increase this year of $0.68 per share, and an increase next year of $0.67 per share.

Lixte Biotechnology Holdings Earnings Growth & LIXT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Rocket Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Lixte Biotechnology Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):